论文部分内容阅读
目的:探究对社区获得性肺炎患者以莫西沙星进行治疗的临床效果。方法:在我院进行治疗的社区获得性肺炎患者110例,按随机投掷法进行分组,对比两组间治疗效果及不良反应。结果:治疗后研究组患者总康复率85.45%,相比于对照组60.00%有所提高,P<0.05。治疗后研究组皮疹10.91%,失眠14.55%、胃肠道反应18.18%相比于对照组625.45%、36.36%、43.64%有所提高,P<0.05。结论:以莫西沙星对社区获得性肺炎患者进行治疗后,明显提高了疾病的康复率,降低了不良反应。
Objective: To investigate the clinical effect of moxifloxacin in patients with community-acquired pneumonia. Methods: One hundred and ten patients with community-acquired pneumonia who were treated in our hospital were divided into two groups according to the random throwing method to compare the therapeutic effects and adverse reactions between the two groups. Results: After treatment, the total recovery rate of the study group was 85.45%, which was significantly higher than that of the control group 60.00% (P <0.05). After treatment, the research group rash 10.91%, insomnia 14.55%, gastrointestinal tract 18.18% compared with the control group 625.45%, 36.36%, 43.64%, P <0.05. Conclusion: Moxifloxacin treatment of patients with community-acquired pneumonia significantly improved the recovery rate of the disease and reduced adverse reactions.